Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Active Ingredients
01 UBLITUXIMAB-XIIY (1)
02 UMBRALISIB TOSYLATE (1)
Applicant
01 TG THERAPEUTICS, INC (1)
02 TG THERAPS (1)
Dosage Form
01 INJECTABLE;INTRAVENOUS (1)
02 TABLET;ORAL (1)
Dosage
01 25 MG/ML (1)
02 EQ 200MG BASE (1)
Country
01 USA (2)